🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yuta Mishima

Harvard University

ORCID: 0000-0003-4945-7346

Also affiliated with University of Tsukuba, Harvard Affiliated Emergency Medicine Residency, Tsukuba Medical Center Hospital, Harvard Stem Cell Institute

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyPhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms”.

Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms

Cancer Science(2021)10.1111/cas.15210
N/A
0DataRank · unranked
6 citations

Juan Luiz Coelho‐Silva, Cristina Tavares Leal, Adriana Queiroz Arantes Rocha, Thiago Mantello Bianco, Robert S. Welner +8 more

Posttranscriptional activity of eIF4E contributes to HoxA9-driven leukemogenesis

Blood Neoplasia(2025)10.1016/j.bneo.2025.100132
N/A
0DataRank · unranked
2 citations

Biljana Culjkovic‐Kraljacic, Christian Bach, Feng Li, Yuta Mishima, Katherine L. B. Borden +2 more

Posttranscriptional activity of the eukaryotic translation initiation factor eIF4E contributes to HoxA9-driven leukemogenesis

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.02.10.637540
N/A
0DataRank · unranked
0 citations

Biljana Culjkovic-Kraljacic, Christian Bach, Feng Li, Yuta Mishima, Katherine L. B. Borden +2 more